What are the recommended CO₂ insufflation techniques and pressure settings for robotic prostatectomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended CO₂ Insufflation Pressure for Robotic Prostatectomy

Use ultralow pneumoperitoneum pressure of 6-8 mmHg for robotic-assisted radical prostatectomy (RARP) rather than the traditional 12-15 mmHg standard pressure.

Pressure Settings

The evidence strongly supports reducing insufflation pressure from traditional levels:

  • Target pressure: 6-8 mmHg is safe, feasible, and provides clinical benefits over standard 12-15 mmHg 1, 2
  • All procedures can be completed at 6 mmHg without needing pressure adjustments, even in patients with BMI ranging from 19.5-44.3 kg/m² 3
  • A randomized controlled trial of 138 patients demonstrated that 6 mmHg is uniformly achievable without compromising surgical outcomes 1

Clinical Benefits of Lower Pressure

Pain reduction: Patients at 6 mmHg experience significantly lower immediate postoperative pain scores (2.1 vs 3.5, p<0.01) and maximum pain scores (3.0 vs 5.2, p<0.01) compared to 15 mmHg 1. Shoulder pain and groin pain are also reduced 1.

Faster recovery:

  • Earlier return of bowel function (flatus at 1.0 vs 1.3 days, p<0.01) 1
  • Reduced postoperative ileus rates: 2% at 8 mmHg vs 4.8% at 12 mmHg 2, with meta-analysis showing OR 0.41 (p=0.006) 4
  • Shorter hospital stay by approximately 0.23 days 4
  • Same-day discharge is feasible in 88% of patients at 6 mmHg 1

Surgical Outcomes Maintained

The most recent high-quality randomized trial 1 demonstrates that ultralow pressure does not compromise surgical quality:

  • No increase in blood loss (similar EBL, no transfusions in either group)
  • No increase in positive surgical margins (OR 1.04, p=0.81) 4
  • Minimal increase in operative time (7-10 minutes longer) 1, 3, which is clinically insignificant
  • No increase in complications - in fact, the 6 mmHg group had lower 30-day readmission rates (1.0% vs 5.7%) 3

Technical Implementation

Starting pressure: Begin at 6-8 mmHg from the outset of the procedure, not as a stepwise reduction.

Maintaining low pressure:

  • Both valveless (AirSeal) and conventional insufflation systems can maintain 6 mmHg throughout the entire procedure 5
  • An experienced bedside assistant moderating suction is helpful when using conventional insufflation 5
  • Valveless systems provide more stable pressure (maximum 7.9 vs 9.9 mmHg) and better smoke evacuation 5

Additional Considerations

Warmed and humidified CO₂: While warmed/humidified insufflation with devices like HumiGard shows minimal benefit in maintaining core temperature (0.2°C difference), it does not improve cytokine levels, pain scores, or other clinical outcomes during RARP 6. This is optional rather than essential.

Physiologic parameters: No adverse effects on PaCO₂, PaO₂, pH, or CO₂ elimination occur at ultralow pressures 5.

Common Pitfalls to Avoid

  • Don't default to "standard" 12-15 mmHg simply because it's traditional - the evidence clearly favors lower pressures
  • Don't increase pressure unnecessarily - all cases can be completed at 6-8 mmHg regardless of patient body habitus 3
  • Don't assume longer operative time is clinically significant - the 7-10 minute increase is offset by improved patient outcomes

The recommendation to use 6-8 mmHg pneumoperitoneum is based on Level 1 evidence from multiple randomized controlled trials 1, 2 and supported by meta-analysis 4, demonstrating clear benefits in morbidity (reduced ileus, pain) and quality of life (faster recovery, same-day discharge) without compromising oncologic or surgical outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.